Tamiflu survives sewage treatmentOctober 03, 2007Swedish researchers have discovered that oseltamivir (Tamiflu); an antiviral drug used to prevent and mitigate influenza infections is not removed or degraded during normal sewage treatment. Consequently, in countries where Tamiflu is used at a high frequency, there is a risk that its concentration in natural waters can reach levels where influenza viruses in nature will develop resistance to it. Widespread resistance of viruses in nature to Tamiflu increases the risk that influenza viruses infecting humans will become resistant to one of the few medicines currently available for treating influenza. "Antiviral medicines such as Tamiflu must be used with care and only when the medical situation justifies it," advises Björn Olsen, Professor of Infectious Diseases with the Uppsala University and the University of Kalmar. "Otherwise there is a risk that they will be ineffective when most needed, such as during the next influenza pandemic." The Swedish research group demonstrated that oseltamivir, the active substance in Tamiflu, passes virtually unchanged through sewage treatment.
"That this substance is so difficult to break down means that it goes right through sewage treatment and out into surrounding waters," says Jerker Fick, Doctor in Chemistry at Ume University and the leader of this study. The Swedish research group also revealed that the level of oseltamivir discharged through sewage outlets in certain countries may be so high that influenza viruses in nature can potentially develop resistance to the drug. "Use of Tamiflu is low in most countries, but there are some exceptions such as Japan, where a third of all influenza patients are treated with Tamiflu," explains Jerker Fick. Influenza viruses are common among waterfowl, especially dabbling ducks such as mallards. These ducks often forage for food in water near sewage outlets. Here they can potentially encounter oseltamivir in concentrations high enough to develop resistance in the viruses they carry. "The biggest threat is that resistance will become common among low pathogenic influenza viruses carried by wild ducks." adds Björn Olsen. These viruses could then recombinate with viruses that make humans sick to create new viruses that are resistant to the antiviral drugs currently available. The Swedish researchers advise that this problem must be taken seriously so that humanity's future health will not be endangered by too frequent and unnecessary prescription of the drug today. Public Library of Science | |||||||||||||||||||||
|
Related Influenza Current Events and Influenza News Articles Stopping germs from ganging up on humans Keeping germs from cooperating can delay the evolution of drug resistance more effectively than killing germs one by one with traditional drugs such as antibiotics, according to new research from The University of Arizona in Tucson. Common cold virus came from birds A virus that causes cold-like symptoms in humans originated in birds and may have crossed the species barrier around 200 years ago, according to an article published in the December issue of the Journal of General Virology. Scientists hope their findings will help us understand how potentially deadly viruses emerge in humans. The health burden of raising a grandchild Precautionary health measures such as mammograms and cholesterol tests that identify the risk of heart disease are critical for the well-being of women over 50. Add the responsibility of providing sustained care for a grandchild, and these preventive examinations become even more important. Protein 'tubules' free avian flu virus from immune recognition A protein found in the virulent avian influenza virus strain called H5N1 forms tiny tubules in which it "hides" the pieces of double-stranded RNA formed during viral infection, which otherwise would prompt an antiviral immune response from infected cells, said Baylor College of Medicine researchers in an online report in the journal Nature. Flu vaccination rates lag for at-risk adolescents Influenza vaccination rates for adolescents who suffer from asthma and other illnesses are still far too low, according to a recent study. New intranasal influenza vaccine triggers robust immunity with significantly less antigen A single administration of a novel, nasally delivered influenza vaccine elicited immune responses in ferrets that were more than 20 times higher than those generated by two injections of the currently approved vaccines, according to a study by NanoBio Corporation. Masks, hand washing, prevent spread of flu-like symptoms by up to 50 percent Wearing masks and using alcohol-based hand sanitizers may prevent the spread of flu symptoms by as much as 50 percent, a landmark new study suggests. Cold virus found to manipulate genes Sneezing, runny nose and chills? You might blame the human rhinovirus (HRV), which causes 30 to 50 percent of common colds. But in reality, it's not the virus itself but HRV's ability to manipulate your genes that is the true cause of some of the most annoying cold symptoms. First comprehensive genomic study of common cold reveals new treatment targets Today, scientists from Procter & Gamble (P&G), the University of Calgary and the University of Virginia announced results from the first study to examine the entire human genome's response to the most common cold virus, human rhinovirus. Vaccinating family members offers important flu protection to newborns Vaccinating new mothers and other family members against influenza before their newborns leave the hospital creates a "cocooning effect" that may shelter unprotected children from the flu, a virus that can be life-threatening to infants, according to researchers at Duke Children's Hospital. More Influenza Current Events and Influenza News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||